Zaghloul Ahmed, Professor of Neuroscience and Motor Control, and Chair of the Department of Physical Therapy/Program in Neuroscience at the College of Staten Island, and PathMaker Neurosystems Inc. (PathMaker) have received a $2.16M grant from the federal government for their continued work on Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s Disease). Ahmed is a co-investigator in this research.
The funding, which was provided by the Congressionally Directed Medical Research Program (CDMRP) at the U.S. Department of Defense’s U.S. Army Medical Research and Development Command (USAMRDC), is part of its FY23 Amyotrophic Lateral Sclerosis Research Program (ALSRP) Pilot Clinical Trial Award, which will fund PathMaker’s expanded pilot project, called the CALM study, “Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability,” using PathMaker’s MyoRegulator® device to treat people with ALS. The trial is set to begin by late 2024 at two leading Boston-area centers, Spaulding Rehabilitation Hospital (SRH) and Beth Israel Deaconess Medical Center (BIDMC). Read more...
